エピソード

  • Targeting the Metabolic Driver: A Forward-Looking Approach to Obesity and Liver Health

    Targeting the Metabolic Driver: A Forward-Looking Approach to Obesity and Liver Health
    2026/09/08

    Discover how emerging targeted therapies address systemic drivers in MASLD and MASH.

    Credit available for this activity expires: 9/8/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/targeting-metabolic-driver-forward-looking-approach-obesity-2026a1000t0l?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    29 分
  • The Whole Patient: Integrating the Lived Experience of Myasthenia Gravis

    The Whole Patient: Integrating the Lived Experience of Myasthenia Gravis
    2026/09/04

    Fatigue, unpredictability, and life goals; integrate what patients say they need into how you treat myasthenia gravis (MG).

    Credit available for this activity expires: 9/4/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/whole-patient-integrating-lived-experience-myasthenia-gravis-2026a1000rf7?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    42 分
  • Epilepsy in General Neurology Practice: Optimizing a Therapeutic Approach From the Start

    Epilepsy in General Neurology Practice: Optimizing a Therapeutic Approach From the Start
    2026/09/01

    Are your epilepsy patients achieving true seizure freedom, or is it time to adjust their therapy?

    Credit available for this activity expires: 9/1/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/epilepsy-general-neurology-practice-optimizing-therapeutic-2026a1000rgh?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    48 分
  • Myasthenia Gravis Guidelines: A Global View for Local Practice

    Myasthenia Gravis Guidelines: A Global View for Local Practice
    2026/08/19

    Compare global myasthenia gravis (MG) guidelines to optimize local, patient-centered treatment pathways.

    Credit available for this activity expires: 8/17/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/myasthenia-gravis-guidelines-global-view-local-practice-2026a1000q15?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    38 分
  • From Mechanism to Management: Applying Evidence for Hemophilia A in the Clinic

    From Mechanism to Management: Applying Evidence for Hemophilia A in the Clinic
    2026/08/18

    Are non-factor therapies enough to protect your hemophilia A patients during surgery?

    Credit available for this activity expires: 8/18/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/mechanism-management-applying-evidence-hemophilia-clinic-2026a1000p5z?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    18 分
  • Updating Our Checklist for Transthyretin Amyloid Cardiomyopathy Monitoring

    Updating Our Checklist for Transthyretin Amyloid Cardiomyopathy Monitoring
    2026/08/14

    Master multimodality imaging and autonomic red flag screening in your transthyretin amyloid cardiomyopathy (ATTR-CM) practice.

    Episode learning points & Disclosures: https://www.medscape.org/viewarticle/updating-our-checklist-transthyretin-amyloid-cardiomyopathy-2026a1000pul?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    42 分
  • Mild Cognitive Impairment and Mild Dementia: Can We Act Before It's Too Late?

    Mild Cognitive Impairment and Mild Dementia: Can We Act Before It's Too Late?
    2026/08/07

    What tests are best to assess early cognitive symptoms?

    Credit available for this activity expires: 03/05/2027
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003254?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    39 分
  • Why Target APRIL in IgA Nephropathy Management? Get Up to Speed With the Mechanisms of Action and Key Data

    Why Target APRIL in IgA Nephropathy Management? Get Up to Speed With the Mechanisms of Action and Key Data
    2026/08/05

    Explore emerging B-cell-targeted therapies for immunoglobulin A nephropathy (IgAN). Unpack novel mechanisms of action (MOAs) and the latest clinical data to protect kidneys now.

    Credit available for this activity expires: 8/5/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/why-target-april-iga-nephropathy-management-get-speed-2026a1000ooh?ecd=bdc_podcast_libsyn_mscpedu
    続きを読む 一部表示
    28 分